"The use of weight loss jabs in a context where thinness is already put on a pedestal and where eating disorders and disordered eating is already a concern, is a recipe for disaster," said Dr Garcia Ashdown-Franks, research fellow at York St John University
The compounded GLP-1 market that made platforms like this one possible has been under sustained regulatory pressure since early 2025 - and the FDA's April 30, 2026 proposal added a new deadline that anyone evaluating a program deserves to understand before submitting an intake form
another might include ingredients that affect absorption
For that group, treating the deficiency is important, because an untreated deficiency does not stay still
doi:10.1016/j.bbi.2026.106295 118
This is not an Orange Book product and has not been subjected to FDA therapeutic equivalency or other equivalency testing